Form 4: Praxis GC Sells Shares for Tax Obligations

Praxis Precision Medicines' General Counsel, Alex Nemiroff, disposed of 89 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Alex Nemiroff, General Counsel and Secretary of Praxis Precision Medicines, Inc., reported a transaction involving the company's common stock.
• On January 7, 2026, Nemiroff disposed of 89 shares of common stock.
• The shares were withheld by the issuer at a price of $292.63 per share.
• This disposition was made to satisfy tax withholding obligations in connection with the vesting of previously reported restricted stock units (RSUs).
• Following this transaction, Nemiroff beneficially owns 20,742.667 shares of Praxis Precision Medicines, Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-arranged.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction for tax purposes related to RSU vesting, which is common for executives. It does not reflect a change in sentiment towards the company or its prospects.

Positives

• The transaction is a routine, non-discretionary sale to cover tax obligations, which is a common practice for executives receiving equity compensation.
• The transaction was executed under a Rule 10b5-1(c) plan, demonstrating adherence to corporate governance best practices for insider trading.

Negatives

• No direct negatives are associated with this routine tax-related transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction, common across all industries for executives receiving equity compensation. It does not provide specific industry context or trends.

Comparison to Industry Standards

• The disposition of shares for tax withholding related to RSU vesting is a standard practice for executives in publicly traded companies across various industries.
• The use of a Rule 10b5-1(c) plan aligns with industry best practices for managing insider stock transactions transparently and avoiding accusations of trading on material non-public information.

Corporate Governance

Related Party Transactions

• The transaction involves an executive (Alex Nemiroff) and the issuer (Praxis Precision Medicines, Inc.) for the purpose of satisfying tax obligations related to equity compensation, which is a standard compensation-related dealing.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction and does not signal a change in company fundamentals or executive confidence.
• Employees: No direct impact on the broader employee base.
• Management: The transaction reflects a standard part of executive compensation and tax management.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by an executive to cover tax obligations associated with RSU vesting. Such transactions are common and pre-scheduled under Rule 10b5-1 plans, and typically do not indicate any change in the executive's confidence in the company or provide new material information that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Praxis Precision Medicines, PRAX, Alex Nemiroff, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Corporate Governance